NASDAQ:LOGC - LogicBio Therapeutics News Headlines

$6.97
-0.79 (-10.18 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$6.39
Now: $6.97
$7.86
50-Day Range
$7.65
MA: $11.21
$13.59
52-Week Range
$6.36
Now: $6.97
$20.07
Volume14,267 shs
Average Volume16,156 shs
Market Capitalization$156.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

LogicBio Therapeutics (NASDAQ LOGC) News Headlines

Source:
DateHeadline
LogicBio Therapeutics (NASDAQ:LOGC) Earns "Buy" Rating from Chardan CapitalLogicBio Therapeutics (NASDAQ:LOGC) Earns "Buy" Rating from Chardan Capital
www.americanbankingnews.com - August 15 at 4:26 PM
LogicBio Therapeutics (NASDAQ:LOGC) Posts Quarterly  Earnings Results, Misses Estimates By $0.04 EPSLogicBio Therapeutics (NASDAQ:LOGC) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - August 14 at 2:43 PM
LogicBio Reports Second Quarter 2019 Financial Results and Provides Business UpdatesLogicBio Reports Second Quarter 2019 Financial Results and Provides Business Updates
finance.yahoo.com - August 13 at 3:53 PM
Contrasting Fennec Pharmaceuticals (NASDAQ:FENC) & LogicBio Therapeutics (NASDAQ:LOGC)Contrasting Fennec Pharmaceuticals (NASDAQ:FENC) & LogicBio Therapeutics (NASDAQ:LOGC)
www.americanbankingnews.com - August 10 at 2:07 PM
LogicBio Therapeutics Inc (NASDAQ:LOGC) Given Average Recommendation of "Buy" by AnalystsLogicBio Therapeutics Inc (NASDAQ:LOGC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - August 9 at 4:30 AM
LogicBio Therapeutics (NASDAQ:LOGC) vs. Crispr Therapeutics (NASDAQ:CRSP) Head-To-Head AnalysisLogicBio Therapeutics (NASDAQ:LOGC) vs. Crispr Therapeutics (NASDAQ:CRSP) Head-To-Head Analysis
www.americanbankingnews.com - August 7 at 4:02 AM
LogiBio nabs rare pediatric disease tag for LB-001; shares up 5%LogiBio nabs rare pediatric disease tag for LB-001; shares up 5%
seekingalpha.com - July 16 at 11:40 AM
Opening Bell, May 31, 2019Opening Bell, May 31, 2019
finance.yahoo.com - May 31 at 11:57 AM
LogicBio to Present at the Jefferies 2019 Healthcare ConferenceLogicBio to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 30 at 12:01 PM
LogicBio Reports First Quarter 2019 Financial Results and Provides Business UpdatesLogicBio Reports First Quarter 2019 Financial Results and Provides Business Updates
finance.yahoo.com - May 14 at 8:38 AM
LogicBio Therapeutics: 1Q Earnings SnapshotLogicBio Therapeutics: 1Q Earnings Snapshot
finance.yahoo.com - May 14 at 8:38 AM
LogicBio Therapeutics Receives FDA Orphan Drug Designation for LB-001 for the Treatment of Methylmalonic AcidemiaLogicBio Therapeutics Receives FDA Orphan Drug Designation for LB-001 for the Treatment of Methylmalonic Acidemia
finance.yahoo.com - April 29 at 11:25 AM
Company’s move into new facilities triples lab spaceCompany’s move into new facilities triples lab space
www.globenewswire.com - April 23 at 11:48 AM
LogicBio Therapeutics Expands Leadership Team and Bolsters Capabilities to Support GeneRide™ Platform Development and Advancement of Lead Program into ClinicLogicBio Therapeutics Expands Leadership Team and Bolsters Capabilities to Support GeneRide™ Platform Development and Advancement of Lead Program into Clinic
finance.yahoo.com - April 22 at 11:28 AM
LogicBio Therapeutics Inc (LOGC.OQ)LogicBio Therapeutics Inc (LOGC.OQ)
www.reuters.com - April 1 at 3:41 PM
LogicBio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdatesLogicBio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates
finance.yahoo.com - April 1 at 10:59 AM
LogicBio Therapeutics: 4Q Earnings SnapshotLogicBio Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - April 1 at 10:59 AM
LogicBio planning first trial of gene editing treatment for children in 2019LogicBio planning first trial of gene editing treatment for children in 2019
www.bizjournals.com - March 7 at 3:35 PM
LogicBio planning first trial of gene editing treatment for childrenLogicBio planning first trial of gene editing treatment for children
finance.yahoo.com - March 7 at 3:35 PM
LogicBio Therapeutics to Present at Upcoming March ConferencesLogicBio Therapeutics to Present at Upcoming March Conferences
finance.yahoo.com - February 25 at 11:41 AM
LogicBio Therapeutics Appoints Kenneth Huttner, M.D., Ph.D., as Senior Vice President, Head of Clinical DevelopmentLogicBio Therapeutics Appoints Kenneth Huttner, M.D., Ph.D., as Senior Vice President, Head of Clinical Development
finance.yahoo.com - February 22 at 9:30 AM
LogicBio Therapeutics Inc.LogicBio Therapeutics Inc.
www.barrons.com - December 13 at 3:19 PM
LogicBio Reports Third Quarter 2018 Financial ResultsLogicBio Reports Third Quarter 2018 Financial Results
finance.yahoo.com - December 3 at 3:17 PM
LogicBio Announces Partnership with Children’s Medical Research Institute to Develop Next Generation Viral VectorsLogicBio Announces Partnership with Children’s Medical Research Institute to Develop Next Generation Viral Vectors
finance.yahoo.com - November 15 at 3:16 PM
LogicBio to Present at the Jefferies 2018 London Healthcare ConferenceLogicBio to Present at the Jefferies 2018 London Healthcare Conference
finance.yahoo.com - November 13 at 3:16 PM
Friday 10/26 Insider Buying Report: LOGC, CFGFriday 10/26 Insider Buying Report: LOGC, CFG
www.nasdaq.com - October 26 at 4:41 PM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel